DaVita Inc/ US23918K1088 /
2024-10-09 7:59:48 PM | Chg. +3.41 | Volume | Bid2024-10-09 | Ask2024-10-09 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
157.76USD | +2.21% | 213,836 Turnover: 18.44 mill. |
157.76Bid Size: 100 | 157.86Ask Size: 800 | 13.21 bill.USD | - | 20.67 |
GlobeNewswire
06-24
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salo...
Newsfile Corp
06-18
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
04-26
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
2023-11-17
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
2023-08-15
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
2022-03-21
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
2022-03-07
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
2022-02-10
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
2021-10-07
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
2021-10-01
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors